Pharmaceutical Products Supply - Gentamicin, Valsartan, Klozapin, Pembrolizumab

Summary

Klinički bolnički centar Rijeka je nabavio četiri vrste lijekova: gentamicin, valsartan s hidroklorotiazidom, klozapin i pembrolizumab. Nabava je provedena pregovaračkim postupkom bez prethodne objave poziva na nadmetanje zbog iznimne žurnosti. Ukupna procijenjena vrijednost nabave iznosi 2.343.501,72 EUR, s najvećim udjelom pembrolizumaba (1.335.672 EUR) i valsartana (1.001.754 EUR).

Klinički bolnički centar Rijeka procured four types of pharmaceutical products: gentamicin, valsartan with hydrochlorothiazide, clozapine, and pembrolizumab. The procurement was conducted through a negotiated procedure without prior call for competition due to exceptional urgency. The total estimated value is EUR 2,343,501.72, with the largest shares for pembrolizumab (EUR 1,335,672) and valsartan (EUR 1,001,754).